January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Cutaneous Head and Neck Melanoma: Better Outcomes with ICIs

Explore the distinct clinicopathological features and treatment outcomes of cutaneous head and neck melanoma versus other melanoma sites.

Conexiant

January 14, 2025

Allergic Multimorbidity Linked to Mucosal Healing in UC

Patients with 3+ allergic conditions had 8x higher odds of achieving mucosal healing, highlighting potential shared immune pathways.

Conexiant

January 14, 2025

Novel Focal Point Technology Controls Laser Treatment Depth

"The focused ring beam spares an island of superficial tissue," researchers report in a new study demonstrating precise depth control in laser treatments while protecting the epidermis.

Conexiant

January 13, 2025

Vitiligo Treatment: ASCS vs. NB-UVB

Autologous skin cell suspension therapy demonstrates effective and durable repigmentation for stable vitiligo, showing higher repigmentation rates compared to narrow-band ultraviolet B therapy alone.

Conexiant

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

November 01, 2024

Are Toothbrushes More Viral Than Showerheads?

Study finds your toothbrush hosts primarily human-associated bacteria including Klebsiella, Streptococcus, and Veillonella, while showerheads harbor environmental microbes.

Conexiant

November 18, 2024

Apocrine Gland Changes in Early Hidradenitis Suppurativa

A recent study in the Journal of Investigative Dermatology identified potential early factors in the development of hidradenitis suppurativa, involving apocrine gland damage and keratin release, offering insights into potential biomarkers for disease severity and progression.

Conexiant

September 09, 2024

First Full Eye, Face Transplant Performed

In a surgical first, retinal cells showed light responsiveness up to 9.0 μv at 220 days after whole eye transplant, nearing the low end of normal (10-50 μv).

Conexiant